Answers are grounded in this paper and cite their sources.
Cytokeratin-positive interstitial reticulum cells (CIRCs) are considered to represent a subset of fibroblastic reticulum cells (FBRCs) belonging to accessory dendritic cells in lymph nodes, the spleen and tonsils.1-3 The tumors arising from CIRCs are so rare that they are easily misdiagnosed as tumors originating from other accessory dendritic cells, myofibroblasts or even metastatic poor-differentiated carcinomas due to their similar histomorphologic features. We report herein one new case of a CIRC tumor (CIRCT) located in the retroperitoneum and analyze the clinicopathologic characteristics, pathogenesis, treatment and prognosis by reviewing the literature. CASE REPORT Clinical findings A 27-year-old man presented to Nanjing Jinling Hospital with complaints of intermittent pain in the left middle quadrant of the abdomen for 4 years. The symptoms occurred one or two times a year. The pain could be completely remitted when he rested or took some anti-inflammatory drugs, but later the pain became progressively worse. Computed tomography scan of the abdominal region showed a large tumor mass in the left middle quadrant with a left kidney dislocation. The patient was then admitted to our hospital. He had no fever, weight loss or other complaints. He had a discontinuous medical history of drug abuse for four years. Laboratory examinations revealed that hepatitis C virus antibody was positive and serum glutamic pyruvic transaminase was abnormal. Serum human immunodeficiency virus was not detected. Exploratory laparotomy was performed under general anesthesia and examination during the operation revealed a large tumor mass located in the retroperitoneum, measuring 12.0 cm×12.0 cm×10.0 cm with a smooth surface and solid texture. A total excision of the tumor mass together with the left kidney was performed due to adherence. The postoperative recovery was uneventful. The patient refused local radiotherapy and showed no signs of relapse 13 months after diagnosis. Pathologic findings Grossly, the oval mass measured 12.0 cm×12.0 cm×10.0 cm was grayish to tan on the cut surface and solid in texture. It had a relatively complete capsule. Hemorrhage and necrosis were not observed. The tumor mass was closely adherent to the left kidney measuring 11.0 cm×10.0 cm×7.0 cm. Microscopically, the architecture of the lymph node was subtotally effaced by the proliferation of spindle tumor cells, leaving a rim of cortex and residual or atrophic follicles in the tumor tissues. Tumor tissue was arranged in a diffusely fascicular, storiform growth pattern or irregularly (Figure 1). Scattered among the collagenous background infiltrated by abundant mature lymphocytes were spindle cells or ill-defined cells, with eosinophilic plasma, vesicular nuclei and distinct nucleoli. The mildly atypical nuclei were round to oval or even kidney-shaped (Figure 2). Nuclear mitotic count was 0-2 per 10 high-power fields. No foci of necrosis or hemorrhage were observed. Reticular fiber staining displayed abundant reticular fibers encompassing single tumor cells or small cell nests.Figure 1.: The tumor issue was arranged in a fascicular, storiform growth pattern. The neoplasm cells were scattered amongst a collagen background infiltrated by some small lymphocytes (HE, original magnification ×200).Figure 2. The spindle-shaped or ill-defined tumor cells showed mildly-atypic vesicular nuclei, prominent nucleoli and distinct nuclear membrane (HE, original magnification ×400).Figure 3. The slender cytoplasmic processes of the tumor cells were highlighted by immunohistochemical staining for cytokeratin 8/18 (Envision, original magnification ×200).Figure 4. EGFR were detected in the membrane and cytoplasma of the tumors cells (Envision, original magnification×400).Figure 5. The tumor cells were positive for SMA in comparison with vascular smooth muscle cells as the internal control (Envision, original magnification ×200).Figure 6. Desmosome-like junctions between the tumor cells were observed (Electron microscopy, Bar=200 nm).Figure 7. The tumor cell nests were surrounded by basement membrane-like material and long-spacing collagen (Electron microscopy, Bar=1 μm).Figure 8. The long-spacing collagen showed 90-110 nm cyclical transverse striation (Electron microscopy, Bar=200 nm).Immunohistochemical findings Immunohistochemical study was performed using En Vision methods on 2 μm formalin-fixed, paraffinembedded sections using a panel of monoclonal antibodies listed in Table 1. Heat-mediated antigen retrieval was run by autoclave treatment (120°C for 2 minutes in 1 mmol/L EDTA, pH 8.0). Color development was performed with 3, 3′-diaminobenzidine (DAB) (Dako, UK). Nuclei were counterstained with hematoxylin. The result of immunostaining was evaluated according to the proportion of tumor cells stained as follows: >50% (+++), 25%-50% (++), 5%-25% (+) and <5% (-). The tumor cells were positive for cytokeratin (CK) AE1/AE2 (+++), CK8/18 (+++, Figure 3), vimentin (+++), epidermal growth factor receptor (EGFR, +++, Figure 4), smooth muscle actin (SMA, ++, Figure 5), lysozyme (+) and α1-antitrypsin (+). The tumor cells were negative for clusterin, CD21+35, S-100, CD1a, CD68, desmin, anaplastic lymphoma kinase-1 (ALK-1), p53, CD3, CD20, CD34, D2-40, CK7 and CK20. The proliferative index, revealed by Ki-67 staining, was approximately 10%. Appropriate positive and negative controls were performed.Table 1: List of primary antibodies used in the case presentedIn situ hybridization findings In situ hybridization for the presence of Epstein-Barr virus (EBV)-encoded small RNA was performed following the manufacturer's instructions on formalinfixed, paraffin-embedded tissue sections using the digoxigenin-labeled oligonucleotides probe specific for the small RNA of EBV (PanPath, Netherlands). The result was negative in the present case. Ultrastructural findings The specimen initially fixed in 10% neutral formalin was subsequently refixed in 2.5% glutaraldehyde, postfixed in 1% osmium tetroxide in 0.1 mol/L phosphate buffer solution (Ph 7.4) and then routinely processed. The ultrathin 60-80 nm sections were examined under a JEM-1200EX transmission electron microscope (JEOL, Tokyo, Japan) after further contrasting with uranyl acetate and lead citrate. The tumor cells had interlaced interdigitating cytoplasmic processes and desmosomelike junctions between the cells (Figure 6). Around some cell nests were discontinuous basement membrane-like material and long-spacing collagen with 90-110 nm cyclical transverse striations (Figures 7 and 8). The tumor cells contained rich cytoplasm, intermediate filaments and dense bodies. A moderate amount of rough endoplasmic reticulum and chondriosomes were observed. Oval nuclei had shallow invaginations and affluent chromatin. The occasional apoptotic tumor cells were characterized by shrinking cells, curly nuclei, highly aggregated chromatin and dissociation from their surrounding cells. CLINICAL OVERVIEW History Accessory dendritic cells in lymph nodes consist of follicular dendritic cells (FDCs), interdigitating dendritic cells, Langerhans cells and FBRCs. FBRCs and reticular fibers together construct the framework of the interstitial reticular system of lymph nodes.2,4 FBRCs can be classified into CK-negative FBRCs and CK-positive FBRCs by immunohistochemical staining for cytokeratins. CK-positive FBRCs are also called CIRCs. In 1987, Franke and Moll first described that CIRCs were located in extrafollicular zone, paracortex and medulla and especially distributed around blood vessels in the human lymph nodes, the spleen and tonsils. They are considered to originate from mesenchymal stem cells.1,2 Three years later, for the first time, Gould et al5 reported 3 cases of CIRCTs. So far 14 cases of FBRC tumors (FBRCTs) had been found to be reported in the Englishlanguage literature including 4 cases of CK-negative FBRCTs6,7 and 10 cases of CIRCTs (including this present case).3,5,8-10 The patients, including 9 men and 5 women, ranged in ages from 13 to 73 years with a mean age of 46.6 years. The predominant sites of tumor involvement were lymph nodes in 12 cases (mediastinal, 5; submandibular, 2; retroperitoneum, 2; supraclavicular, 1; epitrochlear, 1; and cervical, 1), and extranodal sites in 2 cases (spleen, 1; and soft tissue, 1). The clinical symptoms varied according to tumor locations. The patients presenting with mediastinal or intra-abdominal lymphadenopathy often had obvious clinical evidence including cough, bloody sputum, dyspnea or abdominal discomfort. Superficial tumors were often characterized by painless, solitary augmented lymph nodes. Systemic symptoms were rarely seen. The masses were measured ranging in size from 1.5 cm to 12.0 cm in their greatest dimension. Hemorrhage and necrosis were not easily observed. The summary of clinicopathologic features of the patients with FBRCTs reported in the literature is listed in Table 2.Table 2: Summary of Clinicopathologic features of the patients with FBRCTs reported in the literaturePathogenesis Etiology of FBRCTs remained undetermined. It was speculated that the hyperplasia of FBRCs was a lesion that is highly reactive to injury or was related to autoimmune disease or immune deficiency.2 In the recurrent lesion of a CIRC sarcoma associated with Castleman's disease described by Kakiuchi et al,9 supernatant from primary cultures contained high levels of IL-6 and VEGF secreted by neoplastic cells. Immunostaining also showed strong reactivity for IL-6 and VEGF in specimen sections, revealing some associations between IL-6, VEGF and CIRC sarcoma. In addition, a karyotypic analysis of the recurrent sarcoma showed 47, XXY with some instability. Immunohistochemically, p53 overexpression was identified in the pleomorphic spindle cells of the primary lesion and metastatic tumor. In the case described by Lucioni et al,10 p53 overexpression was also higher in recurrent lesions (60%) than in the primary lesion (20%). We presume that P53 protein may participate in the malignant transformation of a CIRCT while the final mechanism warrants further investigation. FDC sarcomas, especially those located in the abdominal cavity, are related to EBV infection.11 The detection of EBV infection was preformed in 9 out of 14 cases of CIRCTs and the results were all negative, suggesting that CIRCTS bore little relation to EBV infection. Human herpes virus type 8 infection was also not detected.5,8-10 STRATEGIES Diagnosis and differential diagnosis The prerequisite of diagnosis is to be aware of the existence of an FBRCT. In the predominant locations, including mediastinum, retroperitoneum or submandibular sites, a solitary, well-defined mass and a large number of spindle cells distributed in a storiform pattern are indicative of the possibility of FBRCTs. The current pathologic diagnosis is based on histopathologic characteristics, immunostaining and electron microscopic findings. It is imperative to differentiate CIRCTs from tumors derived from other accessory dendritic cells, myofibroblasts and metastatic poorly-differentiated carcinomas. According to the International Lymphoma Study Group, six immunohistochemical markers (CD68, lysozyme, CD1a, S100, CD21, and CD35) are used to divide the tumors of histiocytes and accessory dendritic cells into four groups: histiocytic sarcoma, Langerhans cell tumor, FDC tumor/sarcoma and interdigitating dendritic cell tumor/sarcoma.12 FBRCTs are not included. CD68 and lysozyme are the specific markers for histiocytes. The negative immunostaining for CD1a, S100, and CD68 is helpful to rule out Langerhans cell tumors and interdigitating dendritic cell tumors. Although CD21 and CD35 are specific for FDCs, some FDC tumors are negative for them.13 Clusterin staining has a higher specificity and sensitivity for FDC tumors compared to CD21 and CD35.14,15 CIRCs have immunostaining for CK8/18, SMA and vimentin.1 The immunoreactivity for EGFR is observed in CIRCs as well as in FDCs,16 so EGFR expression has no significance in the differential diagnosis of the two types of tumors. Electron microscopic findings reveal that the neoplasmic cells of CIRCTs have slender cytoplasmic projections and desmosome-like junctions between the tumor cells, supporting the expression of CK in CIRCs. True desmosomes are rarely seen and Birbeck granules are absent, so FDC tumors and Langerhans cell tumors can be ruled out. Basement membrane-like material and long-spacing collagen between the tumor cells are easily identified, which is consistent with the findings of reticular fiber staining in our case. Rich intermediate filaments and dense bodies in the cytoplasm, which correspond to the expression of vimentin and SMA, reveal that the CIRCTs derive from mesenchymal tissue and have bi-directional differentiation features towards epithelioid and myoid/myofibroblastic cells. CIRCTs in lymph nodes coexpress cytokeratins, so another alternative diagnosis is the metastatic poorly differentiated carcinoma, especially lymphoepithelial carcinoma. The possibility can be eliminated since the tumor cells in poorly differentiated carcinomas often have a greater degree of cytologic atypia, more nuclear mitotic figures and epithelial characteristics under electron microscope. In addition, metastatic poorly differentiated carcinomas usually have primary sites and EBV infection is often detected in lymphoepithelial carcinomas. Another important differential diagnosis is inflammatory myofibroblastic tumors (IMTs) which are often positive for ALK-1 and desmin. Ultrastructural features of myofibroblasts differing from FBRCs included fibronexus junction, a special transmembrance structure connecting intracellular microfilaments and extracellular fibronectin.17,18 Desmosome-like junctions are not identified in myofibroblasts. However, cytokeratin may be positive in some IMTs. The difficulties in distinguishing a CIRCT from a CK-positive, but ALK-1- and desmin-negative IMT show a close relationship between the two entities. Nonaka et al17 presented some evidence that so-called IMT might be a proliferative lesion of FBRCs. The two entities might be included in the same tumor spectrum with IMTs representing the low-grade phase while FBRCTs represent the high-grade phase of the same tumor with aggressive characteristics. We speculate that some CK-positive, ALK-1-negative IMTs may be CIRCTs rather than genuine IMTs. A special marker for CIRCs is expected for the diagnosis of CIRCTs. Treatment and prognosis Twelve out of 14 cases of FBRCTs were treated by surgical excision, of which 5 cases were supplemented by adjuvant radiotherapy and 1 case by adjuvant chemotherapy. The other two underwent radiotherapy alone or chemotherapy combined with radiotherapy. There was no uniformly efficacious therapeutic regimen of radiotherapy or chemotherapy. Follow-up information was available in 11 patients, with a follow-up duration of 8 months to 12 years. One patient had local recurrence and 4 patients had metastasis to distant lymph nodes, lung and liver. In the 4 patients with metastasis, 3 patients died of disease at 8 months, 9 months, and 10 months, respectively. The remaining 6 cases were alive and well. The overall recurrence, metastasis, and mortality rates of the 11 cases were 9.1%, 36.4%, and 27.3%, respectively. The general therapy efficacy for FBRCTs showed variability. The role of chemotherapy and radiotherapy was not clearly defined and there was only a partial response or brief remission in some cases.8,10 For non-metastatic cases, surgery alone or surgery followed by adjuvant radiotherapy seemed to achieve survival longer than 12 years.5 However, there was no such efficacious treatment that could prevent the malignant process and prolong the life span for the cases with distant metastasis. In follicular dendritic cell tumors, it appeared that intraabdominal location, presence of coagulative necrosis, high mitotic count (≥5/10 HPF) and lack of adjuvant therapy were associated with an unfavorable prognosis.19 Unfortunately, in FBRCTs, we did not find any relationship of the clinical process and prognosis to histomorphological characteristics, including cell atypia, nuclear mitotic figures and necrosis. It may be due to limited case number, the correlation of clinical prognosis to clinical variables such as age, sex, tumor location, size and treatment was not significant. Only two cases indicated higher cell atypia, frequent nuclear mitotic figures and occurrence of necrosis when the two cases relapsed and underwent malignant transformation. The two patients died of distant metastasis.9,10 CLINICAL DIFFICULTIES Because of limited number of cases, CIRCTs are not well known at present. The clinical difficulties are listed as follows: (1) Difficulties in diagnosis: as mentioned above, CIRCTs had no peculiar clinical symptoms or histomorphological features, so the diagnosis mainly depended on immunohistochemistry and electron microscopy. In addition, the specimens, especially fresh specimens, need to be fixed in a timely manner and strictly processed. (2) Diversification in clinical process: the natural histories of the 14 cases of FBRCTs were variable. Some patients were cured by surgery alone. But some tumors were highly aggressive, resulting in distant metastasis or death within 1 year. So, the biological behavior was difficult to predict. (3) Lack of efficacious therapy: there had not been a feasible therapeutic regimen for those with distant metastasis. Total excision of the tumor mass was the primary therapy. When the nuclear mitotic figures and the proliferative index are increased, radiotherapy or/and chemotherapy are suggested to be given as soon as possible to try to prevent the distant metastasis and extend the life span. Although cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) and radiotherapy have been used to treat FDC sarcoma and Castleman's disease with good effect, respectively,20,21 whether they can be used on CIRCTs or not will deserved further investigation. Based on the high expression of IL-6, VEGF and EGFR in FBRCTs,9,16 the antibodies or inhibitors of the three markers may have the potential for adjuvant therapy for FBRCTs. PERSONAL OPINIONS In summary, we report a rare case of CIRCT of the lymph node. The obvious discrepancy between the ubiquity of CIRCs in lymph nodes, the spleen or tonsils, and the rarity of reported CIRCTs in the literature is difficult to explain. Misdiagnosis as other accessory dendritic cell tumors or metastatic cancers may be the main cause. Maybe not included in the classification of the tumors of histiocytes and accessory dendritic cells, CIRCTs are not usually considered in clinical pathological diagnosis. For further study of CIRCTs, we believe that CIRCTs should be included in the classification of stromal tumors of lymphatic tissue as they are normally present in lymph nodes or extranodal lymph tissues. Acknowledgments: We are grateful to JIANG Shao-jun, MA Heng-hui and LU Zhen-feng for their skillful assistance and the clinical and follow-up information.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: